AVOGARO, ANGELO
 Distribuzione geografica
Continente #
NA - Nord America 43.009
AS - Asia 12.254
EU - Europa 8.523
SA - Sud America 2.427
AF - Africa 2.329
OC - Oceania 263
Continente sconosciuto - Info sul continente non disponibili 124
Totale 68.929
Nazione #
US - Stati Uniti d'America 41.745
SG - Singapore 3.900
CN - Cina 3.110
HK - Hong Kong 2.115
BR - Brasile 1.656
IT - Italia 1.313
DE - Germania 1.038
FI - Finlandia 984
SE - Svezia 761
VN - Vietnam 727
PL - Polonia 554
FR - Francia 499
GB - Regno Unito 461
UA - Ucraina 427
RU - Federazione Russa 359
NL - Olanda 273
IN - India 252
IE - Irlanda 152
CI - Costa d'Avorio 150
TR - Turchia 149
MX - Messico 141
AT - Austria 123
IQ - Iraq 121
AR - Argentina 116
CA - Canada 112
EC - Ecuador 109
ES - Italia 108
AE - Emirati Arabi Uniti 90
ZA - Sudafrica 89
JP - Giappone 86
KR - Corea 84
SA - Arabia Saudita 83
PY - Paraguay 81
PE - Perù 80
AL - Albania 76
CZ - Repubblica Ceca 76
MA - Marocco 75
NI - Nicaragua 75
KE - Kenya 74
GR - Grecia 73
GF - Guiana Francese 72
GT - Guatemala 71
IS - Islanda 71
ID - Indonesia 70
JM - Giamaica 70
JO - Giordania 70
GA - Gabon 69
KZ - Kazakistan 69
TN - Tunisia 69
YT - Mayotte 69
CO - Colombia 68
AU - Australia 67
KG - Kirghizistan 67
UY - Uruguay 67
VE - Venezuela 67
NZ - Nuova Zelanda 66
DZ - Algeria 65
NO - Norvegia 65
PA - Panama 65
TT - Trinidad e Tobago 65
AM - Armenia 64
GH - Ghana 64
NP - Nepal 64
UG - Uganda 64
BE - Belgio 63
HT - Haiti 63
UZ - Uzbekistan 63
AZ - Azerbaigian 62
MK - Macedonia 62
PH - Filippine 62
CG - Congo 61
CH - Svizzera 61
CY - Cipro 61
IR - Iran 61
LA - Repubblica Popolare Democratica del Laos 61
LY - Libia 60
BJ - Benin 59
CR - Costa Rica 59
RO - Romania 59
RS - Serbia 58
SN - Senegal 58
DJ - Gibuti 57
MD - Moldavia 57
CM - Camerun 56
EG - Egitto 56
HU - Ungheria 56
ME - Montenegro 56
PK - Pakistan 56
BD - Bangladesh 55
BO - Bolivia 55
HR - Croazia 55
LU - Lussemburgo 55
DK - Danimarca 54
EE - Estonia 54
IL - Israele 54
LB - Libano 54
ML - Mali 54
PT - Portogallo 54
TZ - Tanzania 54
ZW - Zimbabwe 54
Totale 66.194
Città #
Fairfield 6.711
Woodbridge 3.945
Houston 3.409
Ashburn 3.257
Chandler 3.008
Ann Arbor 2.622
Seattle 2.515
Singapore 2.345
Cambridge 2.302
Wilmington 2.239
Hong Kong 2.057
Jacksonville 1.763
Boardman 921
Princeton 851
Beijing 787
Santa Clara 720
San Diego 638
Medford 455
Roxbury 453
Bytom 443
Dong Ket 433
Helsinki 385
Nanjing 377
Des Moines 363
Guangzhou 363
Padova 282
Munich 233
Shanghai 190
New York 172
Los Angeles 171
Abidjan 140
Shenyang 131
São Paulo 130
Dublin 122
Nanchang 114
Ho Chi Minh City 100
Hefei 99
Hebei 97
London 93
Milan 92
Dearborn 90
Turku 81
Jiaxing 79
Nuremberg 73
Tianjin 73
Vienna 73
Managua 72
Buffalo 70
Changsha 69
Libreville 67
Amman 65
Norwalk 65
Jinan 63
Hanoi 62
Kampala 62
Nairobi 62
Panama City 62
Baku 61
Chicago 60
Dakar 58
Rome 58
Bishkek 57
Rio de Janeiro 56
San Francisco 56
Tashkent 56
Cotonou 55
Montevideo 55
Brooklyn 53
Cayenne 53
Warsaw 53
Accra 52
Council Bluffs 52
Yerevan 52
Djibouti 51
Andorra la Vella 50
Bamako 50
Ogden 50
Reykjavik 50
Harare 49
Vientiane 49
Guatemala City 48
Lusaka 48
Noumea 48
Podgorica 48
Phnom Penh 47
Dar es Salaam 46
Frankfurt am Main 46
Redwood City 46
Castries 45
Luanda 45
Nouakchott 45
Praia 45
Quito 45
Boston 44
Dushanbe 44
Istanbul 44
Lima 44
Mamoudzou 44
Ulan Bator 44
Auckland 43
Totale 48.861
Nome #
miR-30c-5p regulates macrophage-mediated inflammation and pro-atherosclerosis pathways 227
DPP-4 inhibitors moderate the risk of genitourinary tract infections associated with SGLT2 inhibitors 226
Bone marrow macrophages contribute to diabetic stem cell mobilopathy by producing Oncostatin M. 224
Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial 222
Endothelial progenitor cells are reduced in acromegalic patients and can be restored by treatment with somatostatin analogs. 219
NETosis delays diabetic wound healing in mice and humans 215
Switching from twice-daily glargine or detemir to once-daily degludec improves glucose control in type 1 diabetes. An observational study 215
Diabetes-associated myelopoiesis drives stem cell mobilopathy through an OSM-p66Shc signaling pathway 207
2 month evening and night closed-loop glucose control in patients with type 1 diabetes under free-living conditions: A randomised crossover trial 201
Vitamin D status and non-alcoholic fatty liver disease in patients with type 1 diabetes 201
Blood expression of matrix metalloproteinases 8 and 9 and of their inducers S100A8 and S100A9 supports diagnosis and prognosis of PDAC-associated diabetes mellitus 197
Head-to-head comparison between flash and continuous glucose monitoring systems in outpatients with type 1 diabetes 196
NETosis is induced by high glucose and associated with type 2 diabetes. 195
Alternative Activation of Human Macrophages Is Rescued by Estrogen Treatment in Vitro and Impaired by Menopausal Status. 192
Mitochondrial Calcium Uptake Is Instrumental to Alternative Macrophage Polarization and Phagocytic Activity 192
Impaired cognitive processing speed in type 1 diabetic patients who had severe/recurrent hypoglycaemia 191
Carotid Plaque Calcification Predicts Future Cardiovascular Events in Type 2 Diabetes 188
A perspective on NETosis in diabetes and cardiometabolic disorders 185
High temporal resolution detection of patient-specific glucose uptake from human ex vivo adipose tissue on-chip. 183
Effects of the SGLT2 inhibitor dapagliflozin on cardiac function evaluated by impedance cardiography in patients with type 2 diabetes. Secondary analysis of a randomized placebo-controlled trial 183
p66Shc deletion or deficiency protects from obesity but not metabolic dysfunction in mice and humans 181
FreeStyle Libre and Dexcom G4 Platinum sensors: Accuracy comparisons during two weeks of home use and use during experimentally induced glucose excursions 181
Altered glucose metabolism and proteolysis in pancreatic cancer cell conditioned myoblasts: searching for a gene expression pattern with a microarray analysis of 5000 skeletal muscle genes 179
Achievement of low density lipoprotein (LDL) cholesterol targets in primary and secondary prevention: Analysis of a large real practice database in Italy 179
Heme oxygenase-1 is an important modulator in limiting glucose-induced apoptosis in human umbilical vein endothelial cells 177
Circulating levels and characterization of microparticles in patients with different degrees of glucose tolerance 176
Switching from twice-daily glargine or detemir to once-daily degludec improves glucose control in type 1 diabetes. An observational study 176
Hyperglycemia, glucocorticoid therapy, and outcome of COVID-19 176
A stepwise approach to assess the impact of clustering cardiometabolic risk factors on carotid intima-media thickness: the metabolic syndrome no-more-than-additive. 174
Randomized summer camp crossover trial in 5-to 9-year-old children: Outpatient wearable artificial pancreas is feasible and safe 174
Circulating myeloid calcifying cells have anti-angiogenic activity via thrombospondin-1 overexpression 174
Acute effects of linagliptin on progenitor cells, monocyte phenotypes, and soluble mediators in type 2 diabetes 173
High-protein diet: a barrier for sodium-glucose co-transporters 2 inhibitors nephroprotective effects? 173
Microangiopathy is independently associated with presence, severity and composition of carotid atherosclerosis in type 2 diabetes. 172
EFFECTS OF CHRONIC ALCOHOL INTAKE ON CARBOHYDRATE AND LIPID-METABOLISM IN SUBJECTS WITH TYPE-II (NON-INSULIN-DEPENDENT) DIABETES 171
Multinight "Bedside" closed-loop control for patients with type 1 diabetes 171
Closed-Loop Artificial Pancreas Using Subcutaneous Glucose Sensing and Insulin Delivery and a Model Predictive Control Algorithm: Preliminary Studies in Padova and Montpellier 169
An unbalanced monocyte polarisation in peripheral blood and bone marrow of patients with type 2 diabetes has an impact on microangiopathy. 169
Development of a multiphoton-multicolor and super-resolution STED microscope for in vivo experiments 168
Diabetes Limits Stem Cell Mobilization Following G-CSF but not Plerixafor. 167
Head-to-head comparison of the accuracy of Abbott FreeStyle Libre and Dexcom G5 mobile 167
Exposure to DPP-4 inhibitors and COVID-19 among people with type 2 diabetes. A case-control study 167
Cardiovascular actions of GLP-1 and incretin-based pharmacotherapy. 166
Metformin improves putative longevity effectors in peripheral mononuclear cells from subjects with prediabetes. A randomized controlled trial. 164
Circulating Progenitor Cell Count Predicts Microvascular Outcomes in Type 2 Diabetic Patients 164
The antidiabetic drug metformin blunts NETosis in vitro and reduces circulating NETosis biomarkers in vivo 164
Insulin-induced glucose control improves HDL cholesterol levels but not reverse cholesterol transport in type 2 diabetic patients. 162
Endothelial progenitor cells as resident accessory cells for post-ischemic angiogenesis. 162
A consensus statement for the clinical use of the renal sodium-glucose co-transporter-2 inhibitor dapagliflozin in patients with type 2 diabetes mellitus 162
Use and effectiveness of dapagliflozin in routine clinical practice. An Italian multicenter retrospective study 162
Diabetes impairs progenitor cell mobilisation after hindlimb ischaemia-reperfusion injury in rats. 161
Multicenter outpatient dinner/overnight reduction of hypoglycemia and increased time of glucose in target with a wearable artificial pancreas using modular model predictive control in adults with type 1 diabetes 161
Improved long-term cardiovascular outcomes after intensive versus standard screening of diabetic complications: an observational study 161
Diabetes causes bone marrow autonomic neuropathy and impairs stem cell mobilization via dysregulated p66Shc and Sirt1 160
A multidisciplinary approach to diabetic foot pathology 160
Short-term statin discontinuation increases endothelial progenitor cells without inflammatory rebound in type 2 diabetic patients. 159
Changes in the Prescription of Glucose-Lowering Medications in Patients With Type 2 Diabetes Mellitus After a Cardiovascular Event: A Call to Action From the DATAFILE Study 159
Procalcific phenotypic drift of circulating progenitor cells in type 2 diabetes with coronary artery disease. 158
Circulating Endothelial Progenitor Cells Are Reduced In Peripheral Vascular Complications of Type 2 Diabetes Mellitus 157
Optimized glycaemic control achieved with add-on basal insulin therapy improves indexes of endothelial damage and regeneration in type 2 diabetic patients with macroangiopathy: a randomized crossover trial comparing detemir versus glargine. 157
Uncarboxylated Osteocalcin Stimulates 25-Hydroxy Vitamin D Production in Leydig Cell Line Through a GPRC6a-Dependent Pathway 157
Defective recruitment, survival and proliferation of bone marrow-derived progenitor cells at sites of delayed diabetic wound healing in mice 156
Integrated kinematics-kinetics-plantar pressure data analysis: A useful tool for characterizing diabetic foot biomechanics. 156
The hazard of (sub)therapeutic doses of anticoagulants in non-critically ill patients with Covid-19: the Padua province experience 156
Acute alcohol consumption improves insulin action without affecting insulin secretion in type 2 diabetic subjects 155
Acute effect of insulin on nitric oxide synthesis in humans: a precursor-product isotopic study 154
Impaired endothelial progenitor cell recruitment may contribute to heart transplant microvasculopathy. 153
Number and function of endothelial progenitor cells as a marker of severity of diabetic vasculopathy. 152
Interplay between gut microbiota and p66Shc affects obesity-associated insulin resistance 151
The effects of dipeptidyl peptidase-4 inhibition on microvascular diabetes complications. 151
Downregulation of the Longevity-Associated Protein SIRT1 in Insulin Resistance and Metabolic Syndrome. Potential Biochemical Mechanisms 150
Synergistic Interactions Among Metabolic Syndrome Components and Homeostasis Model Assessment of Insulin Resistance in a Middle-Aged General Population over Time. 149
Hypovitaminosis D is associated with lower urinary tract symptoms and benign prostate hyperplasia in type 2 diabetes 149
Individually Adaptive Artificial Pancreas in Subjects with Type 1 Diabetes: A One-Month Proof-of-Concept Trial in Free-Living Conditions 149
Dietary intake and major food sources of polyphenols in people with type 2 diabetes: The TOSCA.IT Study 149
Diabetes induces p66(shc) gene expression in human peripheral blood mononuclear cells: Relationship to oxidative stress 148
Systemic and vascular inflammation in an in-vitro model of central obesity 148
Simvastatin Rapidly and Reversibly Inhibits Insulin Secretion in Intact Single-Islet Cultures 148
Characterization of endothelial progenitor cells 147
Comparison of lower limb muscle strength between diabetic neuropathic and healthy subjects using OpenSim 147
At the crossroads of longevity and metabolism: the metabolic syndrome and lifespan determinant pathways 146
Feasibility of outpatient fully integrated closed-loop control: first studies of wearable artificial pancreas. 146
The peritoneum as a natural scaffold for vascular regeneration. 146
Brain function rescue effect of lactate following hypoglycaemia is not an adaptation process in both normal and Type I diabetic subjects 145
The p66(Shc) redox adaptor protein is induced by saturated fatty acids and mediates lipotoxicity-induced apoptosis in pancreatic beta cells. 145
Persistent reduction of circulating myeloid calcifying cells in acromegaly. Relevance to the bone-vascular axis 145
A perspective on sirtuins in the metabolic syndrome. 145
Circulating CD34(+) cells, metabolic syndrome, and cardiovascular risk 143
Cerebrovascular disease in diabetes mellitus: the role of carotid intima-media thickness. 143
Endothelial progenitor cells and the diabetic paradox. 143
A polymorphism at the IL6ST (gp130) locus is associated with traits of the metabolic syndrome 141
Alcohol intake impairs glucose counterregulation during acute insulin-induced hypoglycemia in IDDM patients. Evidence for a critical role of free fatty acids 140
Accuracy and reliability of continuous glucose monitoring systems: a head-to-head comparison. 140
Inhibition of SGLT-2 rescues bone marrow cell traffic for vascular repair. Role of glucose control and ketogenesis 140
Day-and-night closed-loop glucose control in patients with type 1 diabetes under free-living conditions:results of a single-arm 1-month experience compared with a previously reported feasibility study of evening and night at home 139
Arrhythmic profile and 24-hour QT interval variability in COVID-19 patients treated with hydroxychloroquine and azithromycin 139
Newly-diagnosed diabetes and admission hyperglycemia predict COVID-19 severity by aggravating respiratory deterioration 139
A new classification of diabetic gait pattern based on cluster analysis of biomechanical data. 139
Pharmacologic targeting of endothelial progenitor cells. 138
Pro-inflammatory monocyte-macrophage polarization imbalance in human hypercholesterolemia and atherosclerosis. 138
Totale 16.637
Categoria #
all - tutte 238.314
article - articoli 216.853
book - libri 367
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.646
Totale 457.180


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20217.361 0 0 235 673 439 711 289 694 1.132 1.211 1.009 968
2021/20228.266 240 867 1.005 618 463 559 367 881 527 171 815 1.753
2022/20236.023 1.276 619 116 734 958 784 38 434 694 61 240 69
2023/20243.023 118 446 297 204 174 231 167 92 115 488 322 369
2024/202512.880 47 879 609 493 1.760 348 695 1.012 1.130 543 2.170 3.194
2025/202611.387 1.975 4.537 4.875 0 0 0 0 0 0 0 0 0
Totale 69.505